Privia Health Group, Inc. (PRVA) Insider Trading

Last 12 months

Insiders sold $22.2M and bought nothing on the open market.

87% of the selling was scheduled in advance under 10b5-1 plans. Chief Executive Officer Parth Mehrotra sold $1.17M on Mar 13, 8.5% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2024.

Net open-market

−$22.2M

0 buys · 24 sales

Under a 10b5-1 plan

87%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Jun 2024

Jun 11, 2024

Get an email when PRVA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 9	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	21,275	$27.67	$589k	11%	Form 4
Jul 7	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	600	$27.57	$17k	0.3%	Form 4
Jul 2 – 6	Matthew Shawn Morris Director	Sold10b5-1 plan 2 parts	112,759	$27.29 average	$3.08M	55%	Form 4
Jul 2	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	24,734	$27.50	$680k	11%	Form 4
Jun 30 – Jul 1	Matthew Shawn Morris Director	Sold10b5-1 plan 3 parts	135,498	$26.32 average	$3.57M	57%	Form 4
Jun 26 – 29	Matthew Shawn Morris Director	Sold10b5-1 plan 2 parts	151,322	$25.33 average	$3.83M	60%	Form 4
Jun 26	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	17,196	$25.18	$433k	7.2%	Form 4
May 11 – 12	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan 2 parts	121,086	$22.56 average	$2.73M	22%	Form 4
May 11	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	3,385	$22.60	$77k	1.5%	Form 4
May 1 – 4	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan 2 parts	8,385	$25.03 average	$210k	3.6%	Form 4
May 1 – 4	Matthew Shawn Morris Director	Sold10b5-1 plan 2 parts	18,113	$24.99 average	$453k	16%	Form 4
Apr 2	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	5,566	$20.85	$116k	2.4%	Form 4
Mar 16	Parth Mehrotra Chief Executive Officer	SoldNo plan	26,509	$22.11	$586k	4.6%	Form 4
Mar 16	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	6,391	$22.11	$141k	2.7%	Form 4
Mar 12 – 13	Parth Mehrotra Chief Executive Officer	SoldNo plan 2 parts	53,992	$21.71 average	$1.17M	8.5%	Form 4
Mar 12 – 13	David Mountcastle EVP & Chief Financial Officer	SoldNo plan 2 parts	13,018	$21.71 average	$283k	5.2%	Form 4
Mar 10	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan	21,097	$22.71	$479k	3.2%	Form 4
Mar 6 – 9	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan 4 parts	63,439	$22.95 average	$1.46M	16%	Form 4
Mar 6 – 9	Edward C Fargis EVP & General Counsel	SoldNo plan 2 parts	9,343	$22.99 average	$215k	10%	Form 4
Mar 6 – 9	David Mountcastle EVP & Chief Financial Officer	SoldNo plan 2 parts	11,006	$22.99 average	$253k	6.1%	Form 4
Feb 26 – 27	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan 2 parts	13,058	$25.03 average	$327k	6.7%	Form 4
Feb 26 – 27	Matthew Shawn Morris Director	Sold10b5-1 plan 2 parts	24,338	$25.00 average	$608k	21%	Form 4
Dec 12, 2025	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	23,887	$25.03	$598k	12%	Form 4
Dec 12, 2025	Matthew Shawn Morris Director	Sold10b5-1 plan	13,647	$25.01	$341k	13%	Form 4
May 12, 2025 – May 13, 2025	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan 2 parts	29,682	$24.74 average	$734k	6.8%	Form 4
May 12, 2025	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	3,322	$24.99	$83k	1.8%	Form 4
Apr 30, 2025 – May 1, 2025	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan 2 parts	32,465	$23.20 average	$753k	6.9%	Form 4
Apr 30, 2025	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	3,445	$23.33	$80k	1.8%	Form 4
Apr 30, 2025	Matthew Shawn Morris Director	SoldNo plan	10,309	$23.33	$241k	11%	Form 4
Apr 2, 2025	David Mountcastle EVP & Chief Financial Officer	SoldNo plan	5,630	$22.38	$126k	2.9%	Form 4
Mar 12, 2025	Parth Mehrotra Chief Executive Officer	Sold10b5-1 plan	10,514	$24.03	$253k	2.2%	Form 4
Mar 10, 2025 – Mar 11, 2025	Parth Mehrotra Chief Executive Officer	SoldNo plan 2 parts	18,934	$24.21 average	$458k	3.8%	Form 4
Mar 10, 2025 – Mar 11, 2025	David Mountcastle EVP & Chief Financial Officer	SoldNo plan 2 parts	5,851	$24.21 average	$142k	2.9%	Form 4
Mar 10, 2025 – Mar 11, 2025	Edward C Fargis EVP & General Counsel	SoldNo plan 2 parts	4,967	$24.21 average	$120k	5.1%	Form 4
Feb 14, 2025	David Mountcastle EVP & Chief Financial Officer	Sold10b5-1 plan	100,000	$25.15	$2.52M	38%	Form 4

Jul 910b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 21,275 at $27.67
$589k
11% of stake
Jul 710b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 600 at $27.57
$17k
0.3% of stake
Jul 2 – 610b5-1 plan
Matthew Shawn Morris
Director · sold 112,759 at avg $27.29
$3.08M
55% of stake
Jul 210b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 24,734 at $27.50
$680k
11% of stake
Jun 30 – Jul 110b5-1 plan
Matthew Shawn Morris
Director · sold 135,498 at avg $26.32
$3.57M
57% of stake
Jun 26 – 2910b5-1 plan
Matthew Shawn Morris
Director · sold 151,322 at avg $25.33
$3.83M
60% of stake
Jun 2610b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 17,196 at $25.18
$433k
7.2% of stake
May 11 – 1210b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 121,086 at avg $22.56
$2.73M
22% of stake
May 11No plan
David Mountcastle
EVP & Chief Financial Officer · sold 3,385 at $22.60
$77k
1.5% of stake
May 1 – 410b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 8,385 at avg $25.03
$210k
3.6% of stake
May 1 – 410b5-1 plan
Matthew Shawn Morris
Director · sold 18,113 at avg $24.99
$453k
16% of stake
Apr 2No plan
David Mountcastle
EVP & Chief Financial Officer · sold 5,566 at $20.85
$116k
2.4% of stake
Mar 16No plan
Parth Mehrotra
Chief Executive Officer · sold 26,509 at $22.11
$586k
4.6% of stake
Mar 16No plan
David Mountcastle
EVP & Chief Financial Officer · sold 6,391 at $22.11
$141k
2.7% of stake
Mar 12 – 13No plan
Parth Mehrotra
Chief Executive Officer · sold 53,992 at avg $21.71
$1.17M
8.5% of stake
Mar 12 – 13No plan
David Mountcastle
EVP & Chief Financial Officer · sold 13,018 at avg $21.71
$283k
5.2% of stake
Mar 1010b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 21,097 at $22.71
$479k
3.2% of stake
Mar 6 – 910b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 63,439 at avg $22.95
$1.46M
16% of stake
Mar 6 – 9No plan
Edward C Fargis
EVP & General Counsel · sold 9,343 at avg $22.99
$215k
10% of stake
Mar 6 – 9No plan
David Mountcastle
EVP & Chief Financial Officer · sold 11,006 at avg $22.99
$253k
6.1% of stake
Feb 26 – 2710b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 13,058 at avg $25.03
$327k
6.7% of stake
Feb 26 – 2710b5-1 plan
Matthew Shawn Morris
Director · sold 24,338 at avg $25.00
$608k
21% of stake
Dec 12, 202510b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 23,887 at $25.03
$598k
12% of stake
Dec 12, 202510b5-1 plan
Matthew Shawn Morris
Director · sold 13,647 at $25.01
$341k
13% of stake
May 12, 2025 – May 13, 202510b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 29,682 at avg $24.74
$734k
6.8% of stake
May 12, 2025No plan
David Mountcastle
EVP & Chief Financial Officer · sold 3,322 at $24.99
$83k
1.8% of stake
Apr 30, 2025 – May 1, 202510b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 32,465 at avg $23.20
$753k
6.9% of stake
Apr 30, 2025No plan
David Mountcastle
EVP & Chief Financial Officer · sold 3,445 at $23.33
$80k
1.8% of stake
Apr 30, 2025No plan
Matthew Shawn Morris
Director · sold 10,309 at $23.33
$241k
11% of stake
Apr 2, 2025No plan
David Mountcastle
EVP & Chief Financial Officer · sold 5,630 at $22.38
$126k
2.9% of stake
Mar 12, 202510b5-1 plan
Parth Mehrotra
Chief Executive Officer · sold 10,514 at $24.03
$253k
2.2% of stake
Mar 10, 2025 – Mar 11, 2025No plan
Parth Mehrotra
Chief Executive Officer · sold 18,934 at avg $24.21
$458k
3.8% of stake
Mar 10, 2025 – Mar 11, 2025No plan
David Mountcastle
EVP & Chief Financial Officer · sold 5,851 at avg $24.21
$142k
2.9% of stake
Mar 10, 2025 – Mar 11, 2025No plan
Edward C Fargis
EVP & General Counsel · sold 4,967 at avg $24.21
$120k
5.1% of stake
Feb 14, 202510b5-1 plan
David Mountcastle
EVP & Chief Financial Officer · sold 100,000 at $25.15
$2.52M
38% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PRVA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Health Services

LFSTLifeStance Health Group, Inc.

PIIIP3 Health Partners Inc.

PNTGThe Pennant Group, Inc.

INNVInnovAge Holding Corp.

USPHU.S. Physical Therapy Inc.

WGSGeneDx Holdings Corp.

OMDAOmada Health, Inc.

DCGODocGo Inc.

Spot a number that looks wrong? Check it in PRVA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PRVA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.